Articles |

Cytokine Modifiers : Pipe Dream or Reality? FREE TO VIEW

Edward Abraham
Author and Funding Information

From the Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver

1998 by the American College of Chest Physicians

Chest. 1998;113(3_Supplement):224S-227S. doi:10.1378/chest.113.3_Supplement.224S
Text Size: A A A
Published online


Therapies that block the actions of interleukin-1 (IL-1) or tumor necrosis factor alpha (TNF-α) have been proposed to be potentially beneficial in critically ill patients with sepsis. Clinical trials demonstrated no survival benefit when the actions of IL-1 were blocked. In contrast, inhibition of TNF-α with either monoclonal antibodies or TNF receptor fusion proteins appeared to improve survival in prospectively defined groups of patients with severe sepsis, including those with dysfunction of two or more organ systems or with septic shock associated with the dysfunction of at least one organ system. Although none of the clinical trials has demonstrated statistically significant improvements in mortality for patients who received anticytokine therapy 28 days before, few of the completed studies were initially powered to achieve statistical significance at the day 28 end point. While the available data suggest that anti-TNF therapies improve survival in groups of patients with sepsis that can be identified by clinical criteria, confirmation of the potentially beneficial effects of anti-TNF agents awaits completion of the large multicenter clinical trials that are presently examining the utility of these therapies.




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543